Altimmune Inc (ALT)
8.66
+0.26
(+3.03%)
USD |
NASDAQ |
Nov 22, 16:00
8.65
-0.01
(-0.12%)
After-Hours: 20:00
Altimmune Stock Buybacks (Quarterly): -0.131M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -0.131M |
June 30, 2024 | 0.00 |
March 31, 2024 | -0.169M |
December 31, 2023 | -72.74M |
September 30, 2023 | -0.59M |
June 30, 2023 | -13.35M |
March 31, 2023 | -0.135M |
December 31, 2022 | 0.00 |
September 30, 2022 | -31.90M |
June 30, 2022 | -24.34M |
March 31, 2022 | -0.113M |
December 31, 2021 | -12.46M |
September 30, 2021 | -0.119M |
June 30, 2021 | -18.18M |
March 31, 2021 | -34.28M |
December 31, 2020 | -22.54M |
September 30, 2020 | -126.94M |
June 30, 2020 | -22.78M |
March 31, 2020 | -0.0567M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | -12.67M |
December 31, 2018 | -33.07M |
September 30, 2018 | -4.335M |
Date | Value |
---|---|
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | -0.0295M |
September 30, 2015 | -0.5671M |
June 30, 2015 | -0.2922M |
March 31, 2015 | -0.0843M |
December 31, 2014 | -2.801M |
September 30, 2014 | -10.07M |
June 30, 2014 | -2.556M |
March 31, 2014 | -2.719M |
December 31, 2013 | 0.05M |
September 30, 2013 | -2.258M |
June 30, 2013 | -3.757M |
March 31, 2013 | -0.0534M |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | -0.039M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-126.94M
Minimum
Sep 2020
--
Maximum
Dec 2019
-19.04M
Average
-6.524M
Median
Stock Buybacks (Quarterly) Benchmarks
Eli Lilly and Co | 446.10M |
Viking Therapeutics Inc | -46.66M |
Amgen Inc | -- |
Avid Bioservices Inc | -- |
NovaBay Pharmaceuticals Inc | -2.858M |